These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Development of a Sustainable Release System for a Ranibizumab Biosimilar Using Poly(lactic-co-glycolic acid) Biodegradable Polymer-Based Microparticles as a Platform. Tanetsugu Y, Tagami T, Terukina T, Ogawa T, Ohta M, Ozeki T. Biol Pharm Bull; 2017; 40(2):145-150. PubMed ID: 28154252 [Abstract] [Full Text] [Related]
6. Surface-functionalized, pH-responsive poly(lactic-co-glycolic acid)-based microparticles for intranasal vaccine delivery: Effect of surface modification with chitosan and mannan. Li Z, Xiong F, He J, Dai X, Wang G. Eur J Pharm Biopharm; 2016 Dec; 109():24-34. PubMed ID: 27569030 [Abstract] [Full Text] [Related]
7. Selective anticancer activity of hydroxyapatite/chitosan-poly(d,l)-lactide-co-glycolide particles loaded with an androstane-based cancer inhibitor. Ignjatović NL, Penov-Gaši KM, Wu VM, Ajduković JJ, Kojić VV, Vasiljević-Radović D, Kuzmanović M, Uskoković V, Uskoković DP. Colloids Surf B Biointerfaces; 2016 Dec 01; 148():629-639. PubMed ID: 27694053 [Abstract] [Full Text] [Related]
8. Enhanced encapsulation and bioavailability of breviscapine in PLGA microparticles by nanocrystal and water-soluble polymer template techniques. Wang H, Zhang G, Ma X, Liu Y, Feng J, Park K, Wang W. Eur J Pharm Biopharm; 2017 Jun 01; 115():177-185. PubMed ID: 28263795 [Abstract] [Full Text] [Related]
11. Chitosan-modified poly(D,L-lactide-co-glycolide) nanospheres for plasmid DNA delivery and HBV gene-silencing. Zeng P, Xu Y, Zeng C, Ren H, Peng M. Int J Pharm; 2011 Aug 30; 415(1-2):259-66. PubMed ID: 21645597 [Abstract] [Full Text] [Related]
12. Formulation of porous poly(lactic-co-glycolic acid) microparticles by electrospray deposition method for controlled drug release. Hao S, Wang Y, Wang B, Deng J, Zhu L, Cao Y. Mater Sci Eng C Mater Biol Appl; 2014 Jun 01; 39():113-9. PubMed ID: 24863206 [Abstract] [Full Text] [Related]
15. Comparative studies on chitosan and polylactic-co-glycolic acid incorporated nanoparticles of low molecular weight heparin. Yang T, Nyiawung D, Silber A, Hao J, Lai L, Bai S. AAPS PharmSciTech; 2012 Dec 01; 13(4):1309-18. PubMed ID: 23054983 [Abstract] [Full Text] [Related]
17. Mechanisms of chitosan-coated poly(lactic-co-glycolic acid) nanoparticles for improving oral absorption of 7-ethyl-10-hydroxycamptothecin. Guo M, Rong WT, Hou J, Wang DF, Lu Y, Wang Y, Yu SQ, Xu Q. Nanotechnology; 2013 Jun 21; 24(24):245101. PubMed ID: 23702815 [Abstract] [Full Text] [Related]
19. [Formulation and process optimization of doxorubicin-loaded PLGA nanoparticles and its in vitro release]. Li JL, Zheng CL, Liu JP, Zhu JB. Yao Xue Xue Bao; 2013 May 21; 48(5):759-66. PubMed ID: 23888702 [Abstract] [Full Text] [Related]
20. Development and characterization of hyaluronic acid decorated PLGA nanoparticles for delivery of 5-fluorouracil. Yadav AK, Agarwal A, Rai G, Mishra P, Jain S, Mishra AK, Agrawal H, Agrawal GP. Drug Deliv; 2010 Nov 21; 17(8):561-72. PubMed ID: 20738221 [Abstract] [Full Text] [Related] Page: [Next] [New Search]